By Michele Maatouk
Date: Thursday 20 Nov 2025
(Sharecast News) - Abbott Laboratories said on Thursday that it has agreed to buy cancer diagnostics firm Exact Sciences for $23bn.
Under the terms of the deal, which is expected to close in the second quarter of next year, Exact Sciences shareholders will receive $105 per share.
Exact Sciences focuses...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news